Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Astrocytic accumulation of tau fibrils isolated from Alzheimer’s disease brains induces inflammation, cell-to-cell propagation and neuronal impairment

    Accumulating evidence highlights the involvement of astrocytes in Alzheimer’s disease (AD) progression. We have previously demonstrated that human iPSC-derived astrocytes ingest and modify synthetic tau fibril...

    Khalid Eltom, Tobias Mothes, Sylwia Libard in Acta Neuropathologica Communications (2024)

  2. Article

    Open Access

    Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion

    Deposition of amyloid beta (Aβ) into plaques is a major hallmark of Alzheimer’s disease (AD). Different amyloid precursor protein (APP) mutations cause early-onset AD by altering the production or aggregation pro...

    María Pagnon de la Vega, Stina Syvänen in Acta Neuropathologica Communications (2024)

  3. Article

    Open Access

    Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease

    The use of transgenic mice displaying amyloid-β (Aβ) brain pathology has been essential for the preclinical assessment of new treatment strategies for Alzheimer’s disease. However, the properties of Aβ in such...

    Mara Zielinski, Fernanda S. Peralta Reyes, Lothar Gremer in Nature Neuroscience (2023)

  4. Article

    Open Access

    Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

    Neuroinflammatory processes have been suggested to play a role in the pathophysiology of neurodegenerative diseases and post-hemorrhagic hydrocephalus, but have rarely been investigated in patients with idiopa...

    Madelene Braun, Gustaf Boström, Martin Ingelsson in Fluids and Barriers of the CNS (2023)

  5. Article

    Open Access

    Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms

    Growing evidence indicates that the pathological alpha-synuclein (α-syn) aggregation in Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) starts at the synapses. Physiologic α-syn is involved in reg...

    Emma Brolin, Martin Ingelsson, Joakim Bergström in Cellular and Molecular Neurobiology (2023)

  6. Article

    Open Access

    Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology

    Tau deposits in astrocytes are frequently found in Alzheimer’s disease (AD) and other tauopathies. Since astrocytes do not express tau, the inclusions have been suggested to be of neuronal origin. However, the...

    Tobias Mothes, Benjamin Portal in Acta Neuropathologica Communications (2023)

  7. Article

    Open Access

    The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease

    Unique strains of α-synuclein aggregates have been postulated to underlie the spectrum of clinical and pathological presentations seen across the synucleinopathies. Whereas multiple system atrophy (MSA) is ass...

    Heather H. C. Lau, Ivan Martinez-Valbuena in Acta Neuropathologica Communications (2023)

  8. Article

    Open Access

    Size matters: the impact of nucleus size on results from spatial transcriptomics

    Visium Spatial Gene Expression (ST) is a method combining histological spatial information with transcriptomics profiles directly from tissue sections. The use of spatial information has made it possible to di...

    Elyas Mohammadi, Katarzyna Chojnowska in Journal of Translational Medicine (2023)

  9. No Access

    Article

    Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

    We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the...

    Anubha Mahajan, Cassandra N. Spracklen, Weihua Zhang, Maggie C. Y. Ng in Nature Genetics (2022)

  10. Article

    Open Access

    New insights into the genetic etiology of Alzheimer’s disease and related dementias

    Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We per...

    Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, Luca Kleineidam in Nature Genetics (2022)

  11. Article

    Open Access

    Challenges at the APOE locus: a robust quality control approach for accurate APOE genoty**

    Genetic variants within the APOE locus may modulate Alzheimer’s disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our ...

    Michael E. Belloy, Sarah J. Eger, Yann Le Guen in Alzheimer's Research & Therapy (2022)

  12. Article

    Open Access

    Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates

    Alzheimer’s disease (AD) and Parkinson’s disease (PD) are characterized by brain accumulation of aggregated amyloid-beta (Aβ) and alpha-synuclein (αSYN), respectively. In order to develop effective therapies, ...

    **ar Rostami, Tobias Mothes, Mahshad Kolahdouzan in Journal of Neuroinflammation (2021)

  13. Article

    Open Access

    Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

    Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating e...

    Juan F. Reyes, Sara Ekmark-Léwen, Marina Perdiki in Acta Neuropathologica Communications (2021)

  14. Article

    Open Access

    Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

    The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. H...

    Julia Remnestål, Linn Öijerstedt, Abbe Ullgren in Translational Neurodegeneration (2020)

  15. No Access

    Article

    α-Synuclein strains target distinct brain regions and cell types

    The clinical and pathological differences between synucleinopathies such as Parkinson’s disease and multiple system atrophy have been postulated to stem from unique strains of α-synuclein aggregates, akin to w...

    Angus Lau, Raphaella W. L. So, Heather H. C. Lau, Jason C. Sang in Nature Neuroscience (2020)

  16. Article

    Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Brian W. Kunkle, Benjamin Grenier-Boley, Rebecca Sims, Joshua C. Bis in Nature Genetics (2019)

  17. No Access

    Article

    Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-analysis of clinicall...

    Brian W. Kunkle, Benjamin Grenier-Boley, Rebecca Sims, Joshua C. Bis in Nature Genetics (2019)

  18. No Access

    Article

    Mosaic loss of chromosome Y in leukocytes matters

    Lars A. Forsberg, Jonatan Halvardson, Edyta Rychlicka-Buniowska in Nature Genetics (2019)

  19. No Access

    Article

    Fine-map** type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

    We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130 European-descent individuals (9% cases), after imputation to high-density reference panels. With these data, we (i) extend th...

    Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R. Robertson in Nature Genetics (2018)

  20. Article

    Open Access

    Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells

    In Parkinson’s disease and other Lewy body disorders, the propagation of pathology has been accredited to the spreading of extracellular α-synuclein (α-syn). Although the pathogenic mechanisms are not fully un...

    Gabriel Gustafsson, Camilla Lööv, Emma Persson in Cellular and Molecular Neurobiology (2018)

previous disabled Page of 2